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Abstract 
Although the healing means 2 types of biological mechanisms that seem to be „pathologic”, the swell and the granulations 
are a normal process in the biology of the human being, representing two systemic functions: the adaptation and the morphogenesis. 
There is a pathological healing in which the fundamental healing phenomenon is deviated from the normal. There are three variable 
parameters responsible for the pathological evolution of a scar: the cellular population, the fundamental matrix and the fibers. The 
healing evolution can be deviated to an intense maturation with an „old”, atrophic scar, or to an incomplete maturation and the result 
is a hypertrophic or a keloid scar. For the hypertrophic scars, the excision and the skin graft lead to good results and the relapses are 
rare; the keloid relapse is always at the border between the graft and the wound edge, or between the two skin grafts. These are the 
considerations for which the treatments are mixed, combined (surgical, drugs, physiotherapy) both in our country and abroad, but the 
results are still frustrating. That is why new, modern methods of treatment are used today: criotherapy, laser, ultrasounds. However, 
even those treatments are not very successful: tissue expander, external press therapy, corticosteroids injections, other 
pharmacological agents (retinoic acid, colchicines, antineoplasics). We propose a regenerative, alternative, non-invasive treatment 
starting from the results we obtained in a research work 4 years ago, when we irradiated the fibroblasts in an electromagnetic high 
frequency millimeter waves field, and we obtained the fibroblasts apoptosis and the reorganization of the collagen fibers by changing 
the piezoelectric emission. 
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The only sure healing, without future problems, 
is the regeneration = the replacement of a certain 
tissue with the same type of tissue, without any 
dysfunctions. 
The cicatrization requires the stopping of the 
lesion with another kind of fibrous tissue, representing a 
“permanent weak point” of the respective structure. It 
means that some requirements of the local mesenchymal 
population, of the epitheliums, inflammatory changes, 
aggressive blood cell migrations, increasing quantities of 
enzymes, cellular mediators and modulators, need to be 
complied.  
Although the healing means 2 types of biological 
mechanisms that seem to be „pathologic”, the swell and 
the granulations are a normal process in the biology of the 
human being, representing two systemic functions: the 
adaptation and the morphogenesis. There is a 
pathological healing in which the fundamental healing 
phenomenon is deviated from the normal. There are three 
variable parameters responsible for the pathological 
evolution of a scar: the cellular population, the 
fundamental matrix, and the fibers. The pathological 
evolution is produced by: 
a.  deviations in the continuity of the healing 
b.  deviations in the reactivity of the organism 
c.  deviations produced by the traumatic agent 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Granulation tissue with inflammatory cells and congested 
blood vessels; hematoxylin-eosin color (objective 40x) 
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Fig. 2 Keloid with abnormally large collagen fibers and 
large fibroblasts; hematoxylin-eosin color (objective 
40x). 
The healing evolution can be deviated to an intense 
maturation with an „old”, atrophic scar, or to an  Fig. 3 Atrophic scar in a 28-year-old man, after losing 20 kg 
 
 
Fig. 4 Retractile scar after a hypertrophic scar, in a 19-year-old girl, 
operated at 4 years old 
 
Fig. 5 Keloid scar after acneea vulgaris 
 
There are 2 modeling steps of a scar: a 
precocious immature step with swelling accesses and 
local accumulation of fundamental matrix, and a late, 
mature step with vascular and cellular involution and 
increased local fibrillar density. The hypertrophic scar and 
its tumor form = keloid, develop after a chronicle 
stagnation process in the modeling phase from the 
immature period, either by the persistence and 
continuous self reproduction of big amounts of „imperfect” 
metaplasia products and/or extracellular structures, or 
from a great irritability (or from an increased production of 
cytokines and TNF) of T-Lymphocytes responsible with 
the recognition and tolerance of the new structures.  
In the first mechanism (imperfect structures 
inflation) the hypertrophic scar develops.  
In the second mechanism (strong vigilance of the 
lymphocytes), the result is the keloid [1].  
Biochemical investigations demonstrated a great 
increase of the active fibroblasts synthesis in the keloid, 
followed in order by the hypertrophic scar, the normal scar 
and the normal skin. The proteinglicans level goes parallel 
with the collagen synthesis. It was observed that this 
cellular activity could be reproduced in the cells cultures 
by treating the fibroblasts with growth factors due to the 
modern research possibilities in the cellular modulators 
and mediator’s field [2, 3, 4]. Some authors (Badalamente 
and contributors, 1992; Kolen and contributors, 1995), 
using imunohistochemistry tests, observed an increased 
activity and an increased level of growth factors (PDGF 
(platelet  derived  growth  factor),  EGF ( epithelial  growth 
factor), TGFβ (transforming growth factorβ) [5]. 
According to their evolution, the scars are [1]: 
-  hypertrophic = with a short evolution 
-  cheloid = with a long evolution 
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-  heteromorphic = with an intermediary 
evolution 
The hypertrophic scars develop after a wound; 
the scar is red, irritable, with a high throwing into relief, 
with cyanosis areas and pruritus in the swelling accesses; 
they whiten at pressure and grow quickly (3-6 months) 
and after that, the scars partially regress (scar with a short 
evolution). It appears everywhere on the human body and 
does not invade the normal skin; the frequency is bigger 
at the age of 5-7. The scars with a great volume cannot 
regress (even after the signs of activity disappear) 
because there is a big amount of collagen in them.  
The keloid scars have a long evolution (years), 
are growing all the time and invade the normal tissues 
around. The keloids look like tumors, are warm, red, firm, 
itching, with exfoliations. These forms are often on the 
back, breastbone, hips; thighs (they are rarely found on 
the penis, eyelids, areolas, scrotum). Keloids are found 
only in humans and occur in 5-15% of the wounds. These 
scars develop in young adults and, usually, not before 
puberty, never on the palms and soles; the average age 
at onset is of 10-30 years old; they are more often 
affecting the Africans, where the transmission is 
autosomally dominant. The evolution is permanent, 
progressive and uninterrupted.  
Keloids and hypertrophic scars are genetically 
associated with HLA-B14, HLA-B21, HLA-Bw16, HLA-
Bw35, HLA-DR5, HLA-DQw3, and blood group A (6). 
For a certain diagnosis between the hypertrophic 
and the keloid scar, one has to examine the limits of the 
scar in the normal tissue around, if the keloid infiltrates, 
invades, and penetrates the normal tissue. 
After Muir [1, 7, 8]: 
-  something is missing in the normal derma 
near the keloid, which usually resists the fibroblast 
invasion in the normal or hypertrophic scar; 
-  the fibroblasts from the keloid scar represent 
a different population compared to the normal, natural 
populations. 
Calman and Copenhagen [9] transplanted 
cheloid from the breastbone to the abdominal skin; the 
cheloid regressed while the donor site scar became 
cheloid even if it had been operated with skin graft from  
the abdomen. This test shows that the cheloid scar 
development is not controlled by abnormalities of the local 
fibroblasts, but there is a deficiency of a defending factor 
of the skin (mechanical or biochemical) [1, 7]. 
Russel and contributors (1988) demonstrated 
that the fibroblasts from the cheloids need less stimulation 
as far as the growing factors are concerned in order to 
proliferate in the cultures than the normal cells. Their 
conclusions were that the cheloid-cells are less exact than 
the normal cells and that they develop in a great density 
in the mediums with less growing factors [1, 7]. 
The collagen fibrils are abundant, immature 
and unorganized (they are more irregular, abnormally 
thick, and have unidirectional fibers arranged in a highly 
stressed orientation).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Fascicles of collagen fibers (keloid scar); Philips 206 S 
electron microscope 
 
The epidermis layer has a quasi-normal aspect 
(Figure 7 a, c and d). We remark a diffuse fibroblast-
histocytes proliferation and some rarely disposed 
chronically inflammatory elements at the dermis level. 
Moreover, pericellular configuration appears like a 
collagen tissue and the proliferation zone extends near 
the hypodermis layer (Figure 7 b and c). 
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D  C 
Fig. 7 Keloid scar – hematoxylin-eosin color, optical microscopy [Novex Holland optical microscope, Carfem Electronic Ltd.] 
 
 
 
There is equilibrium between the collagen 
synthesis and the destruction in the normal mature 
scar. In the keloids’ case, the immaturity is explained by a 
failure of the equilibrium favorable for the synthesis, the 
collagen destruction being normal. We can see the 
immaturity at many levels (collagen, fibroblasts, 
glycozaminoglicans, miofibroblasts, enzymatic and 
immunity markers, mastocytes). The collagen is structural 
and histochemically immature. Type 3 collagen is more 
immature in comparison with type 1 collagen (normal, 
mature collagen). The fibroblast proliferates and the 
metabolic answer is greater (instead of diminishing). 
Miofibroblasts are responsible for the keloid contracture. 
Mastocytes are normal in the normal scar after maturation 
and, are more in the keloid, being responsible for the 
congestive accesses. The arterial supply is abundant and 
is responsible for the red color that becomes pale after 
pressure and with the cyanosis areas during the swelling 
accesses. This intense arterial supply with embryonic 
characters keeps the anti-tissue aggressiveness of T 
lymphocytes. The enzymatic changes are the increase of 
the energetic metabolism enzymes, the decrease of the 
proteolitic enzymes, with the increase of the protein 
synthesis. The increase of the acid phosphatase and 
glyco-6-phosphate-dehidrogenasis is a characteristic way 
of evolution for keloid scars. From the immune point of 
view, the local increase of IgG, α1 antitrypsin and 2 
macroglobulin is compulsory. 
The modern biology and physiology tissue 
studies brought out the concept of epithelial-
mesenchymal transition [7, 10, 11]. The epithelium and 
the mesenchyma represent the two fundamental cellular 
phenotypes of the organisms. These two phenotypes 
have different intracellular structures and different 
extracellular bundles with other cells and with the 
extracellular matrix. However, it was demonstrated that 
these different cellular types are interconvertible. The first 
mechanism of epithelial-mesenchymal translation consists 
in the molecular effect of adhesion between cells. The 
second mechanism is that of integrins, which assure the 
connection between the mesenchymal cells and the 
intercellular matrix. The third mechanism consists in the 
effect of the ligand molecules on the cellular receptors, 
which (after becoming activated) initiate ways of 
signalizing, conducting to cellular reorganization. These 
particular mechanisms of the normal cells and tissues can 
be adulterated by different pathological situations. 
Changes of the intern medium, the composition or 
structure of integrins, adhesins, cytokins produced by 
fibroblasts [1] and mostly by the vascular ones [7] are 
responsible with the cellular changes including 
differentiation, epithelial-mesenchymal translation and 
even malignity (Marjolin ulceration). Qualitative and 
quantitative changes of tenascyna, fibronectines, 
glucosaminoglicans, the adulteration of the fibronexus 
(the matrix and the intracellular fibers α-actin, desmin, 
vymentin, microfibers and microtubulatures), were found. 
The changes in the structure and chemistry of the ligand 
cells are produced by the oncogenes or by the alteration 
of the enzymology in the tissue medium.  
The phenotypical translation from epithelium to 
connective and reverse represents an important signal for 
the beginning of the healing phenomenon. The 
transformation from epithelium to mesenchyma and 
reverse is called metaplasyc transmutation. The ration 
cell-fundamental matrix is controlled by the blood vessel 
that secreted the cytokines, quinines, prostaglandines, 
eicosanoides [1].  
For the hypertrophic scars, the excision and the 
skin graft lead to good results and the relapses are rare; 
the keloid relapse always at the border between the graft 
and the wound edge, or between two skin grafts.  
Fetus cicatrization 
The fetus cicatrization starts in the same way the 
adult does, with intra and extra vascular coagulation, with 
an increase in the permeability of the vessels and the 
opening of the interstices, with the development of the 
fibrin barrier at the edge of the hotbed and a massive 
healing granulation. 
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What is missing, in comparison with the adult 
cicatrization is the action of the specialized cells for 
phagocytosis, which are responsible for the pain and 
reactivity of the adult’s wounds. 
The fetus and embryo cells contain, just like the 
adult’s cells, the enzymatic device responsible for the 
cellular suicide dissolution and disappearance; but these 
are centrally commanded, directly by the activity of the 
genes, and the commanding centre is always situated in 
the interior of the cell. In that way, there is no need for 
specialized killer cells, the embryo cells being able to 
sacrifice, an action that is often observed in the fetus-
embryo enlightening. 
What is specific for these cells, are the intense 
cytokinic activity, conducting existing functions and 
becoming the same nature partners in the 
epithelium/mesenchym or endothelium/mesenchym ratio. 
The absence of the important cellular 
aggressions, which produce the adult’s tissue 
shortcomings and permanent cytokinic activity, 
fundamental for the life of these cells, can explain the 
healing without scar, by means of the tissue regeneration. 
After Kratz and contributors (1993), the healing 
of the fetus wounds inside the pregnant uterus is 
fundamental, different in the adult, in accordance with the 
result of the healing, and according to the way of healing, 
this being due to the amniotic liquid (Samasundaram and 
Pratham, 1972). The last authors demonstrated that the 
deviation of the amniotic liquid from the uterine cavity, 
disturbs the fetus cicatrization (Dahl and contributors, 
1983; Kujawa and Tepperman, 1983) and Lomcarer and 
contributors (1990) demonstrated an important quantity of 
hyaluronic acid and amniotic liquid. 
Moreover, Ackle (1981) indicates that the 
amniotic epithelial cells do not contain antigens (HLA-A-B-
C-DR), and when these are subcutaneously implanted to 
volunteers, they do not induce rejection. The serum 
obtained from the volunteer hosts does not contain HLA 
anticorps. By using 3H Minida on cultures of human 
tissues (fibroblasts and keratinocytes) Kratz and 
contributors indicated that the amniotic liquid has mitogen 
effects like the supra insemination of amniotic cells. They 
suggest that the growth factors produced by the amniotic 
cells are responsible for the way of healing of the fetus. 
The exocrine activity of the amniotic cells can 
explain (Adjick and contributors, 1985), at least partially, 
the influence on the healing of the wound, observed even 
in adult, while using the amniotic membrane as a biologic 
dressing (Colocho and contributors, 1974; Faulk and 
contributors, 1980). One can conclude that, the 
keratinocytes and fibroblasts of the fetus, are intensively 
stimulated by the amniotic liquid, at least in the tissue 
cultures. Green and contributors, Mulvihill and 
contributors (1979, 1986), Hagerstramd and contributors 
(1979), Talmi and contributors (1990), Kratz and 
contributors (1993), recommend (using these 
information), the use of fresh, alive amnios grafts and 
the application of the amniotic liquid in the 
prophylaxis of hypertrophic and keloid scars. 
Laboratory data (Krummer and contributors, 
1988) show that the fetal scar can become hypertrophic 
by treating the wound with TGF-beta, suggesting that the 
healing of the fetus and embryo is not influenced by the 
cytokines. 
Generally, there are some intrinsic and extrinsic 
differences between the fetus and the adult, probably 
influencing the healing (Garnier-Lyounet and contributors, 
1993): the fetal skin is in a permanent warm, sterile, 
humid, hypoxic and rich in growth factors, ambiance. The 
amniotic liquid is a source of hyaluronic acid, fibronectine, 
and contains (Longaker and contributors, 1991) an 
inhibiting factor of the contraction, which is acting in a 
ratio with the dose. 
The actual stage of the clinical treatment of 
the pathologic scars 
For the hypertrophic scars, the surgical excision 
and the grafts can induce good results with rare relapses. 
The cheloid always relapses at the junction 
between the graft and the skin edge or between grafts or 
at the new suture level.  
These are the reasons why attempts of 
combined treatments (surgery, drugs, Rx-therapy, 
physiotherapy) have been made both in our country and 
abroad, but the results are only partially satisfactory. 
Studies that lead to the development of the 
therapies associated with the surgical treatment of the 
pathologic scars have been made; however, they are 
more or less efficient (if we are speaking about costs and 
side effects).  
The tissue expanders lead to good results by 
removing the pathologic skin and replacing it with a 
healthy one, but it is a method which cannot be used 
everywhere on the surface of the body because there are 
some clear limitations (irradiated tissue, infections, 
chemotherapy, less vascularized tissues, psychological 
diseases). 
Another method was the external pressotherapy 
by using clothes (gloves, pants, stays, cowls) or elastic 
dressings and silicon devices. This method is partially 
efficient as an adjuvant treatment. 
The treatment of pathologic scars was always a 
touchstone for surgeons and that is why many 
pharmacological methods have been tried all over the 
world. Corticosteroids were directly injected in the little 
scars and together with the pressotherapy some good 
results have been obtained. Other pharmacologic agents 
used, were: colchicines (they decreased the fibroblastic 
secretion of the collagen, increased the collagenasic 
activity and inhibited the wound contraction in the 
systemic therapy); penicillamine, zinc salts (local 
applications), antineoplasics (were used for the tumor 
origin theory about the keloid scars, but there are too 
many risks of the treatment). 
Retinoic acid (acts like a monokine with intense 
activity against fibroblastic secretion and proliferation, 
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being the strongest drug against keloid scars, but the 
costs are too high, and this is a limit for its use on a large 
scale): decreases normal tonofilament and keratohyalin 
synthesis, increases the production of mucoid substances 
and the epidermal cell growth rate, and inhibits DNA 
synthesis in vitro [12, 13]. 
Interferon (IFN) therapy showed a significant 
increase in the rate of scar improvement compared with 
the control period of time (P = .004) after injecting 9 
patients who had hypertrophic scars, with 1 X 106 units of 
human recombinant IFN alfa-2b subcutaneously, daily for 
7 days, and then 2 X 106 units 3 times per week for 24 
weeks in total. Scar assessment (P <.05) and scar volume 
(P <.05) also improved after 3 months of treatment. No 
recurrences were reported after stopping the IFN therapy 
[14]. 
Our proposal for the development of a 
regenerative, alternative, non-invasive treatment of 
the keloid scars 
5 years ago, we have started a research about 
the activated fibroblast with an increased installment of 
collagen synthesis (immature collagen type III), after the 
irradiation in electromagnetic field produced by the 
millimeter waves (of extremely high frequency). The 
experimental investigations represented the theoretical 
base of the paper “Study of the irradiation effects in 
electromagnetic field produced by the millimeter waves 
upon cells of adulterated palmary aponeurosis in 
Dupuytren's disease”. The most important observations 
are the following: the EHF-EMF irradiations produced an 
inhibiting effect on the activated fibroblasts in Dupuytren 
Disease, leading to the apoptosis of fibroblasts involved in 
the anarchical synthesis of collagen, and a new 
reorganization of the collagen fibers by changing the 
piezoelectric emission [15, 16].  
A long time ago, it had been demonstrated 
(Cohen and contributors, 1971; Craig and contributors, 
1975; Diegel and contributors, 1979) [6] that there are 
activated fibroblasts in the keloid, which present an 
increased installment, like in Dupuytren Disease. 
If we take into account the experimental aspects 
discussed earlier and, corroborate them with the scientific 
background in the literature, we would be able to see the 
possibility that, in the initial stages of the scars 
development, this kind of unconventional treatment can 
lead the cicatrization biological process to normal healing, 
by preventing the deviation to pathologic healing. If the 
pathologic scars were already constituted, and if we 
associate the classical surgical treatment, it is possible to 
decrease or eliminate the relapse potential. 
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